Abstract:Neuroimage measures from magnetic resonance (MR) imaging, such as cortical thickness, have been playing an increasingly important role in searching for biomarkers of Alzheimer's disease (AD). Recent studies show that, AD, mild cognitive impairment (MCI) and normal control (NC) can be distinguished with relatively high accuracy using the baseline cortical thickness. With the increasing availability of large longitudinal datasets, it also becomes possible to study the longitudinal changes of cortical thickness and their correlation with the development of pathology in AD. In this study, the longitudinal cortical thickness changes of 152 subjects from 4 clinical groups (AD, NC, Progressive-MCI and Stable-MCI) selected from Alzheimer's Disease Neuroimaging Initiative (ADNI) are measured by our recently developed 4 D (spatial+temporal) thickness measuring algorithm. It is found that the 4 clinical groups demonstrate very similar spatial distribution of grey matter (GM) loss on cortex. To fully utilize the longitudinal information and better discriminate the subjects from 4 groups, especially between Stable-MCI and Progressive-MCI, 3 different categories of features are extracted for each subject, i.e., (1) static cortical thickness measures computed from the baseline and endline, (2) cortex thinning dynamics, such as the thinning speed (mm/year) and the thinning ratio (endline/baseline), and (3) network features computed from the brain network constructed based on the correlation between the longitudinal thickness changes of different regions of interest (ROIs). By combining the complementary information provided by features from the 3 categories, 2 classifiers are trained to diagnose AD and to predict the conversion to AD in MCI subjects, respectively. In the leave-one-out cross-validation, the proposed method can distinguish AD patients from NC at an accuracy of 96.1%, and can detect 81.7% (AUC = 0.875) of the MCI converters 6 months ahead of their conversions to AD. Also, by analyzing the brain network built via longitudinal cortical thickness changes, a significant decrease (p < 0.02) of the network clustering coefficient (associated with the development of AD pathology) is found in the Progressive-MCI group, which indicates the degenerated wiring efficiency of the brain network due to AD. More interestingly, the decreasing of network clustering coefficient of the olfactory cortex region was also found in the AD patients, which suggests olfactory dysfunction. Although the smell identification test is not performed in ADNI, this finding is consistent with other AD-related olfactory studies.

Longitudinal Structural MRI Analysis and Classification in Alzheimer's Disease and Mild Cognitive Impairment.

Classification and Interpretability of Mild Cognitive Impairment Based on Resting-State Functional Magnetic Resonance and Ensemble Learning.

Classification of Alzheimer’s disease progression based on sMRI using gray matter volume and lateralization index

Distinct Atrophy Pattern of Hippocampal Subfields in Patients with Progressive and Stable Mild Cognitive Impairment: A Longitudinal MRI Study

Grey-matter volume as a potential feature for the classification of Alzheimer’s disease and mild cognitive impairment: an exploratory study

Longitudinal Structural MRI Study in Process of Mild Cognitive Impairment Converting to AD Dementia

Analysis of Structural Brain MRI and Multi-Parameter Classification for Alzheimer's Disease.

Classification of MRI and Psychological Testing Data Based on Support Vector Machine.

Early-Stage Identification and Pathological Development of Alzheimer's Disease Using Multimodal MRI.

Discriminative Analysis of Early-Stage Alzheimer’s Disease and Normal Aging with Automatic Segmentation Technique in Subcortical Gray Matter Structures: a Multicenter in Vivo MRI Volumetric and DTI Study

Combined Support Vector Machine Classifier and Brain Structural Network Features for the Individual Classification of Amnestic Mild Cognitive Impairment and Subjective Cognitive Decline Patients

Prediction of clinical and biomarker conformed Alzheimer’s disease and mild cognitive impairment from multi-feature brain structural MRI

Definition and analysis of gray matter atrophy subtypes in mild cognitive impairment based on data-driven methods

Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease

Characterizing MRI biomarkers for early prediction of amnestic mild cognitive impairment among the community‐dwelling Chinese

Discriminant Analysis of Longitudinal Cortical Thickness Changes in Alzheimer's Disease Using Dynamic and Network Features

An Efficient Approach For Differentiating Alzheimer'S Disease From Normal Elderly Based On Multicenter Mri Using Gray-Level Invariant Features

Long Range Early Diagnosis of Alzheimer's Disease Using Longitudinal MR Imaging Data

Classifying MCI Subtypes in Community-Dwelling Elderly Using Cross-Sectional and Longitudinal MRI-Based Biomarkers.

STRUCTURAL ABNORMALITIES OF LIMBIC SYSTEM SERVE AS POTENTIAL BIOMARKERS FOR THE ONSET AND PROGRESSION OF MILD COGNITIVE IMPAIRMENT